Close Menu
Fund Focus News
    Facebook X (Twitter) Instagram
    Trending
    • Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?
    • Dynamic Funds announces September 2025 cash distributions for Dynamic Active ETFs and ETF Series
    • EQ Fund Solutions Partners with Pristine Advisers to Strengthen Proxy Defense and Shareholder Engagement for Closed-End Funds
    • Ballard Sip and Ship to close after 23 years
    • Key Investments to Support Camden Residents
    • Jio BlackRock sees India’s mutual fund industry tripling by 2032
    • Best flexi-cap mutual funds: Top 3 schemes with up to 100 pc absolute returns in just 3 years – Money News
    • SIP vs lumpsum: How investors can decide the right strategy for wealth creation
    Facebook X (Twitter) Instagram
    Fund Focus News
    • Home
    • Bonds
    • ETFs
    • Funds
    • Investments
    • Mutual Funds
    • Property Investments
    • SIP
    Fund Focus News
    Home»Bonds»Eli Lilly Stock Finishes Lower After News of Bond Sale to Fund Morphic Deal
    Bonds

    Eli Lilly Stock Finishes Lower After News of Bond Sale to Fund Morphic Deal

    August 12, 2024


    Key Takeaways

    • Eli Lilly is selling bonds to fund the acquisition of drug developer Morphic. The sale is reportedly worth $5 billion.
    • The company’s stock was upgraded by Deutsche Bank analysts following its quarterly results last week.
    • Lilly shares jumped early in the day but closed in the red.

    Eli Lilly (LLY) shares finished Monday lower after a back-and-forth session in which an analyst upgrade sent them higher before news of $5 billion in bond sales pulled them into the red.

    Deutsche Bank analysts called the drugmaker a “high growth unicorn” and upgraded its shares to a buy rating. The bump was based in part on sales of the weight-loss drug Mounjaro, which more than tripled to $3.09 billion when the company reported earnings last week

    The firm upgraded its price target to $1,025 from $725, a nearly 15% premium to Lilly’s Friday closing price. Shares rose above $904 Monday morning. 

    Bonds Help Fund Morphic Acquisition

    The stock gave back its early gains after Bloomberg in a report said the company would sell $5 billion in bonds to help pay for its $3.2 billion acquisition of Morphic (MORF). Lilly in a regulatory filing confirmed the sale but offered fewer details.

    The deal, announced last month, adds Morphic’s flagship developmental drug for inflammatory bowel disease to Lilly’s portfolio. The company is also developing molecules intended to treat autoimmune diseases, pulmonary hypertensive diseases, fibrotic diseases, and cancer.

    Lilly will sell bonds in five chunks, including a 40-year note with a 1% higher yield than a U.S. Treasury note, according to the report. Corporate bonds are typically seen as riskier than U.S. government bonds, so they usually have higher interest rates to compensate.

    An Eli Lilly spokesperson declined to comment. Shares of the company closed Monday’s session down less than 1%,



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    Nestle Issues 1.1 Billion Euros in New 8-Year, 13-Year Euro Bonds

    September 16, 2025

    Anyone with Premium Bonds savings alerted over £30,000 threshold

    September 16, 2025

    Fundswire article | Trustnet

    September 16, 2025
    Leave A Reply Cancel Reply

    Top Posts

    The Shifting Landscape of Art Investment and the Rise of Accessibility: The London Art Exchange

    September 11, 2023

    Charlie Cobham: The Art Broker Extraordinaire Maximizing Returns for High Net Worth Clients

    February 12, 2024

    YieldMax® ETFs Announces Distributions on ULTY, CONY, FIAT, HOOY, LFGY and Others

    September 17, 2025

    The Unyielding Resilience of the Art Market: A Historical and Contemporary Perspective

    November 19, 2023
    Don't Miss
    Mutual Funds

    Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

    September 17, 2025

    On the lookout for a Sector – Tech fund? Starting with Putnam Global Technology A…

    Dynamic Funds announces September 2025 cash distributions for Dynamic Active ETFs and ETF Series

    September 17, 2025

    EQ Fund Solutions Partners with Pristine Advisers to Strengthen Proxy Defense and Shareholder Engagement for Closed-End Funds

    September 17, 2025

    Ballard Sip and Ship to close after 23 years

    September 17, 2025
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    EDITOR'S PICK

    Investments, blind trusts, TFSAs: what do they mean for this election?

    March 28, 2025

    Shun Ho Property Investments Limited annonce la nomination des membres du comité de nomination

    May 23, 2025

    3 Pine Belt organizations awarded funding through Dollar General Literacy Foundation

    August 22, 2024
    Our Picks

    Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

    September 17, 2025

    Dynamic Funds announces September 2025 cash distributions for Dynamic Active ETFs and ETF Series

    September 17, 2025

    EQ Fund Solutions Partners with Pristine Advisers to Strengthen Proxy Defense and Shareholder Engagement for Closed-End Funds

    September 17, 2025
    Most Popular

    🔥Juve target Chukwuemeka, Inter raise funds, Elmas bid in play 🤑

    August 20, 2025

    ₹10,000 monthly SIP in this mutual fund has grown to ₹1.52 crore in 22 years

    September 17, 2025

    ₹10,000 monthly SIP in this mutual fund has grown to nearly ₹83 lakh in 16 years

    September 16, 2025
    © 2025 Fund Focus News
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.